Document is current
Any future updates will be listed below
-
Authors
Ogata, Hiroaki
Tsubouchi, Kazuya
Takano, Tomotsugu
Maeda, Megumi
Oda, Futoshi
Okamoto, Isamu
Fukuda, Haruhisa
-
Funding
Funding for this research was provided by:
the Japan Science and Technology Agency FOREST Program (JPMJFR205J)
- License Information
-
More Information
Article History
Received: 2 February 2026
Accepted: 30 March 2026
First Online: 7 April 2026
Declarations
:
: This study was approved by the Kyushu University Observational Research Ethics Review Committee (approval number 22114-01) and was conducted in accordance with the principles of the Declaration of Helsinki. Informed consent was waived because of the retrospective nature of the study and because the analysis was based on anonymous clinical data.
: Not applicable.
: KT has received grants from Nippon Boehringer Ingelheim. IO has received grants and personal fees from Daiichi Sankyo, Chugai Pharma, Eli Lilly Japan, AstraZeneca, Taiho Pharmaceutical, Nippon Boehringer Ingelheim, and Ono Pharmaceutical; grants from Bristol-Myers Squibb and MSD Oncology; and personal fees from Takeda Pharmaceutical and Novartis Pharma. All other authors report no relevant conflicts of interest.
